Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV Drug Resistance Surveillance in Honduras after a Decade of Widespread Antiretroviral Therapy.

PloS one - 1 Jan 2015

Avila-Ríos Santiago, García-Morales Claudia, Tapia-Trejo Daniela, Meza Rita I, Nuñez Sandra M, Parham Leda, Flores Norma A, Valladares Diana, Pineda Luisa M, Flores Dixiana, Motiño Roxana, Umanzor Víctor, Carbajal Candy, Murillo Wendy, Lorenzana Ivette, Palou Elsa Y, Reyes-Terán Gustavo

Abstract excerpt

INTRODUCTION: We assessed HIV drug resistance (DR) in individuals failing ART (acquired DR, ADR) and in ART-naïve individuals (pre-ART DR, PDR) in Honduras, after 10 years of widespread availability of ART. METHODS: 365 HIV-infected, ART-naïve, and 381 ART-experienced Honduran individuals were enrolled in 5 reference centres in Tegucigalpa, San Pedro Sula, La Ceiba, and Choluteca between April 2013 and April...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to CD4-Positive T-Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Demography

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Prevalence

Share to RNA, Viral

Source

Open in PubMed Open full text

Identifiers

PMID: 26558396
DOI: 10.1371/journal.pone.0142604
PMCID: PMC4641727

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV Drug Resistance Surveillance in Honduras after a Decade of Widespread Antiretroviral Therapy.PMID 26558396Read ↗

Prevalence of resistance mutations in HIV-1-Infected Hondurans at the beginning of the National Antiretroviral Therapy Program.Semantic proximity Read ↗

Prevalence of drug resistance and importance of viral load measurements in Honduran HIV-infected patients failing antiretroviral treatment.Semantic proximity Read ↗

Drug resistance prevalence in human immunodeficiency virus type 1 infected pediatric populations in Honduras and El Salvador during 1989-2009.Semantic proximity Read ↗

Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

HIV-1 drug resistance surveillance in antiretroviral treatment-naive individuals from a reference hospital in Guatemala, 2010-2013.Semantic proximity Read ↗

Prevalence and patterns of HIV transmitted drug resistance in Guatemala.Semantic proximity Read ↗

Drug resistance in children and adolescents with HIV in Panama.Semantic proximity Read ↗

HIV-1 Antiretroviral Drug Resistance Mutations in Treatment Naïve and Experienced Panamanian Subjects: Impact on National Use of EFV-Based Schemes.Semantic proximity Read ↗

HIV drug resistance in persons initiating or reinitiating first‐line antiretroviral therapy in Paraguay: Results of a National Patient SurveySemantic proximity Read ↗

Antiretroviral drug resistance mutations in antiretroviral-naive patients from Senegal.Semantic proximity Read ↗

Short communication: high prevalence of drug resistance in HIV type 1-infected children born in Honduras and Belize 2001 to 2004.Semantic proximity Read ↗

Genomic surveillance of Plasmodium falciparum and Plasmodium vivax cases at the University Hospital in Tegucigalpa, Honduras.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.